Maternal data | |
---|---|
Women on L-thyroxine therapy (% of the total) | 82% |
Anti-TPO antibody positivity (% of the total) | 97% |
Anti-TG antibody positivity (% of the total) | 61% |
TRAb positivity (% of the total) | 0% |
TSH (mU/L) | 1.7 ± 0.9 |
FT4 (pg/ml) | 10.3 ± 4.5 |
FT3 (pg/ml) | 4.5 ± 4.4 |